+39 331 386 7522 info@isheo.com

Patient Registries For Cell And Gene Therapies

Anemia and CKD

Patient registries are the backbone of clinical research and development. This article explains how they are essential in understanding how individual therapies work and getting them approved by regulatory agencies, especially for Cell and Gene Therapies.

What is a patient registry, and why do they matter?

A patient registry is a database of information on patients that have a particular disease or condition. This information can include demographics, medical history, treatment history, and outcomes. Registries are essential for cell and gene therapies because they can help to identify patients who may be eligible for these treatments, track the progress of patients receiving these treatments, and collect data on the safety and efficacy of these treatments.

Why is there a need for a patient registry?

The US Food and Drug Administration (FDA) has approved or cleared 19 gene therapies since 2011, but the treatment is still in its infancy. These therapies are intended to treat rare diseases, which means the number of patients that could potentially be eligible for these treatments is small. According to FDA data, even with a large potential pool of patients, only a few hundred people have been treated so far in the US. Small pools of patients also leave little opportunity to study the safety and effectiveness of these new treatments over time. That’s why researchers are working on registries that track the progress of patients who receive cell and gene therapies – including their outcomes and quality-of-life measures.

Although the idea of using a registry sounds straightforward, it is difficult to get funding from drug companies, which aren’t yet required by law to fund these registries. In some cases, drug makers have refused to give out information about their new treatments altogether.

Plenty of pharmaceutical companies say they are actively working on developing a patient registry for Cell and Gene therapy products. Still, we’ve yet to come across a well-developed result. Naturally, the life sciences industry’s goal is to put patients at the centre of everything we do, which includes developing programs that support the monitoring of patients for the long term. Most companies are still working on details of how a registry will work, with whom, and how they would maintain any such registry. So when can we expect that patient registries for Cell and Gene Therapies? That answer remains elusive.

What is a Cell or Gene Therapy?

A cell or gene therapy is a type of treatment that uses cells or genes to target and treat diseases. These therapies can potentially be very effective, but they can also be very complex and expensive. That’s why patient registries are so important.

Patient registries are databases of information about people treated with cell or gene therapies. They can help track the long-term effects of these treatments and help researchers learn more about how well they work.

Since Cell and Gene Therapies are still relatively new, we’re still learning much about them. Therefore, patient registries are crucial for helping us understand these treatments and making sure they are safe and effective.

How are cell and gene therapies used to treat various diseases?

Cell and gene therapies treat various diseases, including cancer, genetic disorders, and infectious diseases. These therapies can replace or repair damaged cells or genes, stimulate the immune system, or deliver drugs directly to diseased cells.

Cell and gene therapies hold great promise for the treatment of many diseases that are currently incurable. However, these therapies are also very complex and expensive. Therefore, it is crucial to have patient registries to ensure that cell and gene therapies are safe and effective.

Patient registries are databases of information about patients treated with cell and gene therapies. These registries allow researchers to track these treatments’ long-term safety and efficacy. They also provide valuable information about patients most likely to benefit from these therapies.

Without patient registries, developing and approving new cell and gene therapies would be very difficult. Therefore, patient registries are essential for the success of these potentially life-saving treatments.

How do patient registries help ensure the safety and efficacy of treatments?

Patient registries are becoming increasingly important in cell and gene therapies. Patient data must be collected and managed as these therapies become more complex and expensive. Patient registries allow for real-time tracking of outcomes and can help identify patterns that we would otherwise miss. They are essential in ensuring that these new therapies are safe and effective.

Patient registries are vital for cell and gene therapies to succeed because they help ensure these treatments’ safety and efficacy. Cell and gene therapies are still relatively new, and as such, a lot is not yet known about them. Patient registries help collect data on these therapies so that researchers can better understand how they work and the potential risks and benefits. Additionally, patient registries can help to identify patients who may be suitable for clinical trials of new cell or gene therapies. Ultimately, patient registries are crucial for helping to ensure that these potentially life-saving treatments are safe and effective.

How do you include patient registries in your ATMP market access strategy?

Cell and gene therapies are revolutionizing how we treat disease, offering hope to patients with previously incurable conditions. However, these therapies come with a unique set of challenges, not the least of which is market access.

Patient registries are one tool that can help overcome some of the challenges associated with cell and gene therapies. By collecting data on patients treated with these therapies, registries can provide valuable insights into their real-world safety and efficacy. This data can then be used to support reimbursement decisions, helping to ensure that patients have access to these life-changing treatments.

If you plan to bring a cell or gene therapy to market, consider how patient registries can fit into your overall market access strategy. With careful planning and execution, patient registries can play a vital role in ensuring that these transformative therapies reach the patients who need them most.

Concluding remarks

For cell and gene therapies to be successful, patient registries are crucial. Patient registries help track the long-term effects of these therapies and allow for a better understanding of how well they work. Additionally, patient registries provide valuable information to researchers developing new cell and gene therapies. Finally, without patient registries, it would be much more challenging to determine the efficacy of these treatments.